Omslagsbild

Immune-related adverse events in small-cell lung cancer patients treated with immune checkpoint inhibitors: a comprehensive analysis from the FDA adverse event reporting system

BackgroundThe discovery and development of immune checkpoint inhibitors (ICIs) have resulted in their application as a novel therapeutic strategy for patients with small-cell lung cancer (SCLC). However, a comprehensive analysis of the potential adverse effects of ICIs in patients with SCLC remains...

Full beskrivning

Sparad:

Bibliografiska uppgifter
Huvudupphovsmän:	Yifeng Bai (Författare, medförfattare), Xiaomei Wang (Författare, medförfattare), Xiaoqin Dai (Författare, medförfattare), Qinghua Ma (Författare, medförfattare), Honglin Hu (Författare, medförfattare)
Materialtyp:	Bok
Publicerad:	Frontiers Media S.A., 2024-10-01T00:00:00Z.
Ämnen:	article
Länkar:	Connect to this object online.
Taggar:	Lägg till en tagg Inga taggar, Lägg till första taggen!

Liknande verk

Cardiac arrhythmias associated with immune checkpoint inhibitors: A comprehensive disproportionality analysis of the FDA adverse event reporting system
av: Feifei Wang, et al.
Publicerad: (2022)

Common Immune-Related Adverse Events of Immune Checkpoint Inhibitors in the Gastrointestinal System: A Study Based on the US Food and Drug Administration Adverse Event Reporting System
av: Xiaoyin Bai, et al.
Publicerad: (2021)

Pericardial Toxicities Associated With Immune Checkpoint Inhibitors: A Pharmacovigilance Analysis of the FDA Adverse Event Reporting System (FAERS) Database
av: Zhuo Ma, et al.
Publicerad: (2021)

Cutaneous Adverse Events of Immune Checkpoint Inhibitors: A Literature Review
av: Zoe Apalla, et al.
Publicerad: (2021)

Delayed immune-related adverse events profile associated with immune checkpoint inhibitors: a real-world analysis
av: Yana Yang, et al.
Publicerad: (2024)

Immune-Related Adverse Events in the Older Adult with Cancer Receiving Immune Checkpoint Inhibitor Therapy
av: Matthew D Biniakewitz, et al.
Publicerad: (2021)

Cutaneous Adverse Events of Targeted Therapies and Immune-Checkpoint Inhibitors in Patients with Melanoma
av: Rita Pimenta, et al.
Publicerad: (2021)

Neurological Adverse Events Related to Immune Checkpoint Inhibitors: A Practical Review
av: François Zammit, et al.
Publicerad: (2024)

Adverse events in different administration routes of semaglutide: a pharmacovigilance study based on the FDA adverse event reporting system
av: Kaibin Niu, et al.
Publicerad: (2024)

Adverse Events Following Immunization
av: L.I. Chernyshova
Publicerad: (2014)

Immune-related adverse kidney events by immune checkpoint inhibitors; a narrative review on current studies
av: Tella Sadighpour, et al.
Publicerad: (2021)

Risk of immune system and skin and subcutaneous tissue related adverse events associated with oxaliplatin combined with immune checkpoint inhibitors: a pharmacovigilance study
av: Chunhong Zhang, et al.
Publicerad: (2024)

Adverse Events of Concurrent Immune Checkpoint Inhibitors and Antiangiogenic Agents: A Systematic Review
av: Ling Gao, et al.
Publicerad: (2019)

Indications and adverse events of teriparatide: based on FDA adverse event reporting system (FAERS)
av: Ming-Tao Wen, et al.
Publicerad: (2024)

Characterization and Prognostic Significance of Cutaneous Immune-Related Adverse Events in Indian Patients on Immune Checkpoint Inhibitor Therapy
av: Prasanna Duraisamy, et al.
Publicerad: (2023)

Current Diagnosis and Management of Immune Related Adverse Events (irAEs) Induced by Immune Checkpoint Inhibitor Therapy
av: Vivek Kumar, et al.
Publicerad: (2017)

Toxicity Associated with Immune Checkpoint Inhibitors: Analysis of Immune-Related Adverse Events with a Pembrolizumab Biosimilar (Pembroria)
av: M. Yu. Fedyanin, et al.
Publicerad: (2023)

Opportunistic Infections and Immune-Related Adverse Events Associated with Administering Immune Checkpoint Inhibitors: A Narrative Review
av: Ranferi Ocaña-Guzmán, et al.
Publicerad: (2023)

Association of thrombocytopenia with immune checkpoint inhibitors: a large-scale pharmacovigilance analysis based on the data from FDA adverse event reporting system database
av: Geliang Liu, et al.
Publicerad: (2024)

ADVERSE EVENTS FOLLOWING IMMUNIZATION OF THE ELDERLY
av: Lúcia Helena Linheira-Bisetto, et al.
Publicerad: (2016)

Gender Differences in the Incidence of Adverse Cardiovascular Events in Cancer Patients Treated with Immune Checkpoint Inhibitors
av: Sheharyar Minhas, MD, et al.
Publicerad: (2020)

Pancreatic Adverse Events Associated With Immune Checkpoint Inhibitors: A Large-Scale Pharmacovigilance Analysis
av: Yue Zhang, et al.
Publicerad: (2022)

Musculoskeletal adverse events induced by immune checkpoint inhibitors: a large-scale pharmacovigilance study
av: Hao Liu, et al.
Publicerad: (2023)

Rheumatic immune-related adverse events from checkpoint inhibitor therapy: a case series
av: Antonella Laria, et al.
Publicerad: (2021)

Immune-Related Adverse Events Associated With Immune Checkpoint Inhibitors for Advanced Non-small Cell Lung Cancer: A Network Meta-Analysis of Randomized Clinical Trials
av: Weidong Zhang, et al.
Publicerad: (2021)

A model‐based meta‐analysis of immune‐related adverse events during immune checkpoint inhibitors treatment for NSCLC
av: Renwei Zhang, et al.
Publicerad: (2022)

Corrigendum: Current Diagnosis and Management of Immune Related Adverse Events (irAEs) Induced by Immune Checkpoint Inhibitor Therapy
av: Vivek Kumar, et al.
Publicerad: (2017)

Management of Immune-Related Adverse Events Associated with Immune Checkpoint Inhibitor Therapy: A Minireview of Current Clinical Guidelines
av: Saralinh Trinh, et al.
Publicerad: (2019)

A disproportionality analysis of FDA adverse event reporting system (FAERS) events for ticagrelor
av: Yunyan Pan, et al.
Publicerad: (2024)

Indication and adverse event profiles of denosumab and zoledronic acid: based on U.S. FDA adverse event reporting system (FAERS)
av: Si Su, et al.
Publicerad: (2023)

Ocular adverse events associated with anti-VEGF therapy: A pharmacovigilance study of the FDA adverse event reporting system (FAERS)
av: Pan Ma, et al.
Publicerad: (2022)

Surveillance on the adverse events following immunization with the pentavalent vaccine in Zhejiang, China
av: Xuejiao Pan, et al.
Publicerad: (2022)

Immune checkpoint inhibitors in cancer therapy: Review of orofacial adverse events and role of the oral healthcare provider
av: Brittany A. Klein, et al.
Publicerad: (2022)

Gastrointestinal disorders as immune-related adverse events
av: Daniele Balducci, et al.
Publicerad: (2021)

Neurological Adverse Events Associated With Esketamine: A Disproportionality Analysis for Signal Detection Leveraging the FDA Adverse Event Reporting System
av: Haoning Guo, et al.
Publicerad: (2022)

Comparing the difference of adverse events with HER2 inhibitors: a study of the FDA adverse event reporting system (FAERS)
av: Yiwen Bao, et al.
Publicerad: (2024)

A real-world pharmacovigilance study of FDA adverse event reporting system events for diazepam
av: Weizhen He, et al.
Publicerad: (2024)

Rheumatic immune-related adverse events associated with immune checkpoint inhibitors compared with placebo in oncologic patients: a systemic review and meta-analysis
av: Shuo Zhang, et al.
Publicerad: (2021)

Gastrointestinal adverse events associated with semaglutide: A pharmacovigilance study based on FDA adverse event reporting system
av: Yamin Shu, et al.
Publicerad: (2022)

Musculoskeletal Adverse Events Associated with PCSK9 Inhibitors: Disproportionality Analysis of the FDA Adverse Event Reporting System
av: Lingqing Ding, et al.
Publicerad: (2022)